New partners join precision medicine consortium
Five new partners have joined CONNECT.
top of page
Norwegian Cancer Precision Medicine Implementation Consortium
Latest news
- Jun 14, 2021
- 2 min
CONNECT educational seminar
Watch the engaging presentations from the first CONNECT educational seminar for the Norwegian oncology community. CONNECT Working Group 1...
- May 31, 2021
- 2 min
CONNECT Seminar on Real-World Data
Learn more about the use of real-world data (RWD) for regulatory processes from two presentations held at a recent CONNECT meeting.
- May 12, 2021
- 1 min
CONNECT Seminar on Horizon Scanning Methods
Learn more about Horizon Scanning Methods from the presentations held at a recent CONNECT meeting.
- Jan 29, 2021
- 3 min
First pharma company joins IMPRESS-Norway
Roche is the first pharmaceutical company included in the national clinical study in cancer precision medicine called IMPRESS-Norway.
- Dec 21, 2020
- 3 min
Landmark public-private agreement for precision cancer medicine
CONNECT is a new initiative aiming to ensure that precision medicine reaches the patients.
- Oct 13, 2020
- 3 min
IMPRESS NORWAY: Large national precision medicine study in cancer
IMPRESS-Norway, a large national study on precision medicine against cancer, starts in the beginning of 2021.
©2021 by CONNECT.
bottom of page